Brief: Aska Pharmaceutical Holdings: Will Convey Concerns To Dalton, Urge To Fulfill Obligation To 'proactively' Provide Information In Accordance With Guidelines And Response Policy
16/09/2025 07:33
Sept 16 (Reuters) - ASKA Pharmaceutical Holdings Co Ltd 4886.T: ASKA PHARMACEUTICAL HOLDINGS CO LTD - NOTICE CONCERNING REPEATED REQUEST MADE TO COMPANY SHAREHOLDERS DALTON ETC. FOR RESPONSES TO INFORMATION LIST PERTAINING TO LARGE-SCALE PURCHASE ETC. ASKA PHARMACEUTICAL HOLDINGS - WILL CONVEY CONCERNS TO DALTON ETC, URGE TO FULFILL OBLIGATION TO 'PROACTIVELY' PROVIDE INFORMATION IN ACCORDANCE WITH GUIDELINES AND RESPONSE POLICY Source text: ID:nTSup8850e Further company coverage: 4886.T
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results